Salinex Nasal Lubricant

Natural health product licensed in Canada

Licence holder: Exzell Pharma Inc.
NPN or DIN-HM: 80029330
Status: Active licence
Licence date: 31 January 2012
Revision date: 14 February 2025
Form: Vaporisateur
Route of administration: Nasale
Application type: Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source
Chlorure de sodium Source : Chlorure de sodium	9 mg/ml

Non-medicinal ingredients

Chlorure de benzalkonium, Polypropylene glycol copolymer, Phosphate de sodium, monobasique, Hydroxyde de sodium, Eau purifiée, d-Sorbitol, Hydroxyethyl Cellulose, EDTA de sodium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	2 Pulvérisateur	minimum: 1 Tous les jours ; maximum: 6 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Promotes nasal and sinus drainage. Helps reduce symptoms of dry, irritated nose. Helps maintain healthy sinuses.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80029330

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 14 February 2025 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.